CHEK1 and acute lymphoblastic leukemia: Reports show that T‐cell acute lymphoblastic leukemia (T‐ALL) cell lines and xenografts are sensitive to inhibitors of ATR, CHK1, and Wee1 (Boudny & Trbusek, 2020).